Shares of Allurion (NYSE:ALUR) soared 70% in post-market trading Thursday after ending the regular session 21% higher on news the company plans to conduct a clinical study of its gastric balloon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback